Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016 (2016), Article ID 9153673, 10 pages
http://dx.doi.org/10.1155/2016/9153673
Research Article

Intraplaque Expression of C-Reactive Protein Predicts Cardiovascular Events in Patients with Severe Atherosclerotic Carotid Artery Stenosis

1First Clinic of Internal Medicine, Department of Internal Medicine, University of Genoa, 6 Viale Benedetto XV, 16132 Genoa, Italy
2Division of Cardiology, Foundation for Medical Researches, Department of Medical Specialties, University of Geneva, 64 Avenue de la Roseraie, 1211 Geneva, Switzerland
3Unit of Toxicology, University Centre of Legal Medicine, Geneva-Lausanne, Rue Michel-Servet 1, 1211 Geneva, Switzerland
4IRCCS AOU San Martino-IST, 10 Largo Benzi, 16132 Genoa, Italy
5Vascular and Endovascular Surgery Unit, Department of Surgery, IRCCS AOU San Martino-IST, 10 Largo Benzi, 16132 Genoa, Italy
6Clinic of Hematology, Department of Internal Medicine, University of Genoa, IRCCS AOU San Martino-IST, 10 Largo Benzi, 16132 Genoa, Italy
7Division of Laboratory Medicine, Department of Genetics and Laboratory Medicine, Geneva University Hospitals, 4 Rue Gabrielle-Perret-Gentil, 1205 Geneva, Switzerland
8Centre of Excellence for Biomedical Research (CEBR), University of Genoa, 9 Viale Benedetto XV, 16132 Genoa, Italy

Received 15 July 2016; Accepted 22 August 2016

Academic Editor: Francesca R. Spinelli

Copyright © 2016 Aldo Bonaventura et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. K. Hansson and P. Libby, “The immune response in atherosclerosis: a double-edged sword,” Nature Reviews Immunology, vol. 6, no. 7, pp. 508–519, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Bottazzi, A. Inforzato, M. Messa et al., “The pentraxins PTX3 and SAP in innate immunity, regulation of inflammation and tissue remodelling,” Journal of Hepatology, vol. 64, no. 6, pp. 1416–1427, 2016. View at Publisher · View at Google Scholar
  3. M. B. Pepys and G. M. Hirschfield, “C-reactive protein: a critical update,” The Journal of Clinical Investigation, vol. 111, no. 12, pp. 1805–1812, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. V. Pasceri, J. Chang, J. T. Willerson, and E. T. H. Yeh, “Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs,” Circulation, vol. 103, no. 21, pp. 2531–2534, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Torzewski, C. Rist, R. F. Mortensen et al., “C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, no. 9, pp. 2094–2099, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. Emerging Risk Factors C, S. Kaptoge, and E. Di Angelantonio, “C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis,” The Lancet, vol. 375, no. 9709, pp. 132–140, 2010. View at Publisher · View at Google Scholar
  7. H.-K. Kuo, C.-J. Yen, C.-H. Chang, C.-K. Kuo, J.-H. Chen, and F. Sorond, “Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis,” The Lancet Neurology, vol. 4, no. 6, pp. 371–380, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Danesh, J. G. Wheeler, G. M. Hirschfield et al., “C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease,” The New England Journal of Medicine, vol. 350, no. 14, pp. 1387–1397, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Montecucco and F. Mach, “New evidences for C-reactive protein (CRP) deposits in the arterial intima as a cardiovascular risk factor,” Clinical Interventions in Aging, vol. 3, no. 2, pp. 341–349, 2008. View at Google Scholar · View at Scopus
  10. T. Wolff, J. Guirguis-Blake, T. Miller, M. Gillespie, and R. Harris, “Screening for carotid artery stenosis: an update of the evidence for the U.S. Preventive Services Task Force,” Annals of Internal Medicine, vol. 147, no. 12, pp. 860–870, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Y. Streifler, “Asymptomatic carotid stenosis: intervention or just stick to medical therapy—the case for medical therapy,” Journal of Neural Transmission, vol. 118, no. 4, pp. 637–640, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. S. M. Schwartz, Z. S. Galis, M. E. Rosenfeld, and E. Falk, “Plaque rupture in humans and mice,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 4, pp. 705–713, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Alvarez Garcia, C. Ruiz, P. Chacon, J. Alvarez Sabin, and M. Matas, “High-sensitivity C-reactive protein in high-grade carotid stenosis: risk marker for unstable carotid plaque,” Journal of Vascular Surgery, vol. 38, no. 5, pp. 1018–1024, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Fittipaldi, R. Pini, G. A. Pasquinelli et al., “High sensitivity c-reactive protein and vascular endothelial growth factor as indicators of carotid plaque vulnerability,” The Journal of Cardiovascular Surgery, In press.
  15. A. Shindo, H. Tanemura, K. Yata et al., “Inflammatory biomarkers in atherosclerosis: pentraxin 3 can become a novel marker of plaque vulnerability,” PLoS ONE, vol. 9, no. 6, Article ID e100045, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. W. J. Jabs, E. Theissing, M. Nitschke et al., “Local generation of C-reactive protein in diseased coronary artery venous bypass grafts and normal vascular tissue,” Circulation, vol. 108, no. 12, pp. 1428–1431, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Calabró, J. T. Willerson, and E. T. H. Yeh, “Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells,” Circulation, vol. 108, no. 16, pp. 1930–1932, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Meuwissen, A. C. van der Wal, H. W. M. Niessen et al., “Colocalisation of intraplaque C reactive protein, complement, oxidised low density lipoprotein, and macrophages in stable and unstable angina and acute myocardial infarction,” Journal of Clinical Pathology, vol. 59, no. 2, pp. 196–201, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Montecucco, N. Vuilleumier, S. Pagano et al., “Anti-Apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerability,” European Heart Journal, vol. 32, no. 4, pp. 412–421, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. F. Montecucco, V. Di Marzo, R. F. Da Silva et al., “The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques,” European Heart Journal, vol. 33, no. 7, pp. 846–856, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Vuilleumier, F. Montecucco, G. Spinella et al., “Serum levels of anti-apolipoprotein A-1 auto-antibodies and myeloperoxidase as predictors of major adverse cardiovascular events after carotid endarterectomy,” Thrombosis and Haemostasis, vol. 109, no. 4, pp. 706–715, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. F. Montecucco, S. Lenglet, A. Gayet-Ageron et al., “Systemic and intraplaque mediators of inflammation are increased in patients symptomatic for ischemic stroke,” Stroke, vol. 41, no. 7, pp. 1394–1404, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. H. J. M. Barnett, D. W. Taylor, M. Eliasziw et al., “Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis,” The New England Journal of Medicine, vol. 339, no. 20, pp. 1415–1425, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Warlow, B. Farrell, A. Fraser, P. Sandercock, and J. Slattery, “Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST),” The Lancet, vol. 351, no. 9113, pp. 1379–1387, 1998. View at Publisher · View at Google Scholar · View at Scopus
  25. MRC Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group, “Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial,” The Lancet, vol. 363, no. 9420, pp. 1491–1502, 2004. View at Publisher · View at Google Scholar
  26. J. L. Stöger, M. J. J. Gijbels, S. van der Velden et al., “Distribution of macrophage polarization markers in human atherosclerosis,” Atherosclerosis, vol. 225, no. 2, pp. 461–468, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. R. A. Fraga-Silva, S. Q. Savergnini, F. Montecucco et al., “Treatment with Angiotensin-(1-7) reduces inflammation in carotid atherosclerotic plaques,” Thrombosis and Haemostasis, vol. 111, pp. 736–747, 2014. View at Publisher · View at Google Scholar
  28. M. Schillinger, M. Exner, W. Mlekusch et al., “Inflammation and carotid artery—risk for atherosclerosis study (ICARAS),” Circulation, vol. 111, no. 17, pp. 2203–2209, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. O. Schlager, M. Exner, W. Mlekusch et al., “C-reactive protein predicts future cardiovascular events in patients with carotid stenosis,” Stroke, vol. 38, no. 4, pp. 1263–1268, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. X. Huang, A. Wang, X. Liu et al., “Association between high sensitivity C-reactive protein and prevalence of asymptomatic carotid artery stenosis,” Atherosclerosis, vol. 246, pp. 44–49, 2016. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Torzewski, M. Torzewski, D. E. Bowyer et al., “C-Reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 18, no. 9, pp. 1386–1392, 1998. View at Publisher · View at Google Scholar · View at Scopus
  32. V. Pasceri, J. T. Willerson, and E. T. H. Yeh, “Direct proinflammatory effect of C-reactive protein on human endothelial cells,” Circulation, vol. 102, no. 18, pp. 2165–2168, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. S. P. Ballou and G. Lozanski, “Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein,” Cytokine, vol. 4, no. 5, pp. 361–368, 1992. View at Publisher · View at Google Scholar · View at Scopus
  34. T. P. Zwaka, V. Hombach, and J. Torzewski, “C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis,” Circulation, vol. 103, no. 9, pp. 1194–1197, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. G. J. Wolbink, M. C. Brouwer, S. Buysmann, I. J. M. Ten Berge, and C. E. Hack, “CRP-mediated activation of complement in vivo: assessment by measuring circulating complement-C-reactive protein complexes,” Journal of Immunology, vol. 157, no. 1, pp. 473–479, 1996. View at Google Scholar · View at Scopus
  36. S. Devaraj and I. Jialal, “C-reactive protein polarizes human macrophages to an M1 Phenotype and inhibits transformation to the M2 phenotype,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 6, pp. 1397–1402, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. S. W. Fong, L. L. Few, W. C. See Too et al., “Systemic and coronary levels of CRP, MPO, sCD40L and PlGF in patients with coronary artery disease,” BMC Research Notes, vol. 8, article 679, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. A. M. Wilson, J. D. Swan, H. Ding et al., “Widespread vascular production of C-reactive protein (CRP) and a relationship between serum CRP, plaque CRP and intimal hypertrophy,” Atherosclerosis, vol. 191, no. 1, pp. 175–181, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. K. Yasojima, C. Schwab, E. G. McGeer, and P. L. McGeer, “Generation of C-reactive protein and complement components in atherosclerotic plaques,” American Journal of Pathology, vol. 158, no. 3, pp. 1039–1051, 2001. View at Publisher · View at Google Scholar · View at Scopus
  40. H. Sun, T. Koike, T. Ichikawa et al., “C-reactive protein in atherosclerotic lesions: its origin and pathophysiological significance,” American Journal of Pathology, vol. 167, no. 4, pp. 1139–1148, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. K. Hatanaka, X.-A. Li, K. Masuda, C. Yutani, and A. Yamamoto, “Immunohistochemical localization of C-reactive protein-binding sites in human atherosclerotic aortic lesions by a modified streptavidin-biotin-staining method,” Pathology International, vol. 45, no. 9, pp. 635–641, 1995. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. Fukuchi, Y. Miura, Y. Nabeno, Y. Kato, T. Osawa, and M. Naito, “Immunohistochemical detection of oxidative stress biomarkers, dityrosine and Nε-(hexanoyl)lysine, and C-reactive protein in rabbit atherosclerotic lesions,” Journal of Atherosclerosis and Thrombosis, vol. 15, no. 4, pp. 185–192, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Pucci, E. Brscic, E. Tessitore et al., “C-reactive protein and coronary composition in patients with percutaneous revascularization,” European Journal of Clinical Investigation, vol. 38, no. 5, pp. 281–289, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. K. C. Koskinas, S. Zaugg, K. Yamaji et al., “Changes of coronary plaque composition correlate with C-reactive protein levels in patients with ST-elevation myocardial infarction following high-intensity statin therapy,” Atherosclerosis, vol. 247, pp. 154–160, 2016. View at Publisher · View at Google Scholar · View at Scopus
  45. R. Molino-Lova, C. Macchi, A. M. Gori et al., “High sensitivity C-reactive protein predicts the development of new carotid artery plaques in older persons,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 21, no. 10, pp. 776–782, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. P. Poredos, A. Spirkoska, L. Lezaic, M. B. Mijovski, and M. K. Jezovnik, “Patients with an inflamed atherosclerotic plaque have increased levels of circulating inflammatory markers,” Journal of Atherosclerosis and Thrombosis, 2016. View at Publisher · View at Google Scholar
  47. H. Grufman, I. Gonçalves, A. Edsfeldt et al., “Plasma levels of high-sensitive C-reactive protein do not correlate with inflammatory activity in carotid atherosclerotic plaques,” Journal of Internal Medicine, vol. 275, no. 2, pp. 127–133, 2014. View at Publisher · View at Google Scholar · View at Scopus